We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ABPI Rebukes Five Drugmakers for Breaching Code of Practice
ABPI Rebukes Five Drugmakers for Breaching Code of Practice
The Association of the British Pharmaceutical Industry found five drugmakers — AstraZeneca, Eli Lilly, Janssen, Boehringer Ingelheim and Grünenthal — violated the trade group’s code of practice by engaging in activities that ranged from deceptive marketing to imprecise training.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor